SEC Form 4 · accession 0001209191-16-138722
Audentes Therapeutics, Inc. · BOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen P Squinto
Director
Period of report
Aug 24, 2016
Accepted (ET)
Aug 25, 2016 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628738
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.03 | Aug 24, 2016 | A | 9,000 | A | — | Aug 24, 2026 | Common Stock | 9,000 | 9,000 | D |
Explanation of responses
- F1The option vests as to 100% of the total shares on the earlier to occur of (a) the issuer's 2017 annual meeting of stockholders and (b) August 24, 2017, subject to the reporting person's provision of service to the issuer on the applicable vesting date.